Diagnosis of acute neuropathies

Journal of Neurology

Volumn 254, Issue 9, 2007, Pages 1151-1169

  Crone, Clarissa ^a   Krarup, Christian ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Electrophysiology; Motor nerve; Nerve conduction studies; Polyneuropathy; Sensory nerve

Indexed keywords

TOXIN;

ACUTE DISEASE; ACUTE INTERMITTENT PORPHYRIA; ARTERITIS; AUTOIMMUNE DISEASE; CANCER; CLINICAL FEATURE; CRITICAL ILLNESS; DEMYELINATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ELECTRODIAGNOSIS; ELECTROMYOGRAM; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MOTOR NEUROPATHY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; POLYNEUROPATHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSORY NEUROPATHY; UREMIA;

ACUTE DISEASE; DIAGNOSIS, DIFFERENTIAL; ELECTRODIAGNOSIS; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 36148983441     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0532-9     Document Type: Review

References (160)

1. Albers JW (2001) Porphyric neuropathy. In: Mendell JR, Kissel JT, Cornblath DR (eds) Diagnosis and management of peripheral nerve disorders. Oxford University Press, Oxford, pp 344-366
2. Albers JW, Donofrio PD, McGonagle TK (1985) Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 8:528-539
3. Albers JW, Kelly JJ (1989) Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 12:435-451
4. Andersen B, Westlund B, Krarup C (2003) Failure of activation of spinal motoneurones after muscle fatigue in healthy subjects studied by transcranial magnetic stimulation. J Physiol 551:345-356
5. Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van Den BN, Jacobs BC, Doorn PA (2002) Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun 70:1202-1208
6. Antoine JC, Absi L, Honnorat J, Boulesteix JM, de Brouker T, Vial C, Butler M, De Camilli P, Michel D (1999) Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors. Arch Neurol 56:172-177
7. Antoine JC, Honnorat J, Camdessanché JP, Magistris M, Absi L, Mosnier JF, Petiot P, Kopp N, Michel D (2001) Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol 49:214-221
8. Asbury AK (1981) Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 9(Suppl):1-5
9. Asbury AK (1987) Sensory neuronopathy. Seminars in Neurology 7:58-66
10. Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:555-566
11. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl):S21-S24
12. Asbury AK, McKhann GM (1997) Changing views of Guillain-Barré syndrome. Ann Neurol 41:287-288
13. Asbury AK, Thomas PK (1995) The clinical approach to neuropathy. In: Asbury AK, Thomas PK (eds) Peripheral nerve disorders 2. Butterworth Heinemann,Oxford, pp 1-28
14. Behse F, Buchthal F (1978) Sensory action potentials and biopsy of the sural nerve in neuropathy. Brain 101:473-493
15. Berger AR, Schaumburg HH (2005) Human toxic neuropathy caused by industrial agents. In: Dyck PJ, Thomas PK (eds) Peripheral Neuropathy. Elsevier Saunders, Philadelphia, pp 2505-2525
16. Berger AR, Schaumburg HH, Schroeder C, Apfel S, Reynolds R (1992) Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology 42:1367-1370
17. Bolton CF (1994) Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. Chest 106:1-2
18. Bolton CF (2001) Critical illness polyneuropathy and myopathy. Crit Care Med 29:2388-2390
19. Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140-163
20. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ (1986) Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 49:563-573
21. Bostock H, Cikurel K, Burke D (1998) Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21:137-158
22. Bradley WG, Verma A (1996) Painful vasculitic neuropathy in HIV-1 infection: Relief of pain with prednisone therapy. Neurology 47:1446-1451
23. Brown WF, Feasby TE, Hahn AF (1993) Electrophysiological changes in the acute "axonal" form of Guillain-Barré syndrome. Muscle Nerve 16:200-205
24. Buchthal F, Kamieniecka Z (1982) The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders. Muscle Nerve 5:265-280
25. Buchthal F, Rosenfalck P (1963) Electrophysiological aspects of myopathy with particular reference to progressive muscular dystrophy. In: Bourne GH,Golarz MN (eds) Muscular dystrophy in man and animals. S. Karger, Basel, New York, pp 193-262
26. Burke D, Kiernan MC, Bostock H (2001) Excitability of human axons. Clin Neurophysiol 112:1575-1585
27. Camdessanché JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, Michel D (2002) Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 125:166-175
28. Chalk CH, Windebank AJ, Kimmel DW, McManis PG (1992) The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 19:346-351
29. Chiba A, Kusunoki S, Obata H, Machinami R,Kanazawa I (1993) Serum anti-GQ(1b) IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome. Clinical and immunohistochemical studies. Neurology 43:1911-1917
30. Cornblath DR, Mcarthur JC, Kennedy PGE, Witte AS, Griffin JW (1987) Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus Type III infection. Ann Neurol 21:32-40
31. Cornblath DR, Mendell JR, Kissel JT (2001) Evaluation of the patient with peripheral neuropathy: the challenges. In: Mendell JR, Kissel JT, Cornblath DR (eds) Diagnosis and management of peripheral nerve disorders.Oxford University Press, Oxford, pp 3-9
32. Creange A, BarlovatzMeimon G, Gherardi RK (1997) Cytokines and peripheral nerve disorders. European Cytokine Network 8:145-151
33. Creange A, Belec L, Clair B, Raphaël J-C, Gherardi RK (1996) Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome. J Neuroimmunol 68:95-99
34. Dalakas MC, Cupler EJ (1996) Neuropathies in HIV infection. Bailliére Tindall, London, Philadelphia, Sydney, Tokyo, Toronto, pp 199-218
35. Dalmau J, Graus F, Rosenblum MK, Posner JB (1992) Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 71:59-72
36. Dalmau J, Gultekin HS, Posner JB (1999) Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 9:275-284
37. Dalmau J, Posner JB (1996) Neurological paraneoplastic syndromes. Springer Seminars in Immunopathology 18:85-95
38. Davies L, Spies JM, Pollard JD, McLeod JG (1996) Vasculitis confined to peripheral nerves. Brain 119:1441-1448
39. de Letter MACJ, Schmitz PIM, Visser LH, Verheul FAM, Schellens RLLA, Op de Coul DAW, van der Meché FGA (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281-2286
40. de Letter MACJ, van Doorn PA, Savelkoul HFJ, Laman JD, Schmitz PIM, Op de Coul DAW, Visser LH, Kros JM, Teepen JLJM, van der Meché FGA (2000) Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokineexpression in the muscle tissue. J Neuroimmunol 106:206-213
41. de Letter MACJ, Visser LH, van der Meché FGA, Ang W, Savelkoul HFJ (2000) Distinctions between critical illness polyneuropathy and axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 68:397-398
42. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280-291
43. Denny-Brown D (1948) Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 11:73-87
44. Di Giovanni S, Mirabella M, D'Amico A, Tonali P, Servidei S (2000) Apoptotic features accompany acute quadriplegic myopathy. Neurology 55:854-858
45. Di Giovanni S, Molon A, Broccolini A, Melcon G, Mirabella M, Hoffman EP, Servidei S (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55:195-206
46. Dorfman LJ (1984) The distribution of conduction velocities (DCV) in peripheral nerves: a review. Muscle Nerve 7:2-11
47. Dorfman LJ, Cummins KL, Abraham GS (1982) Conduction velocity distributions of the human median nerve: comparison of methods. Muscle Nerve 5:S148-S153
48. Dyck PJB, Windebank AJ (2002) Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 25:477-491
49. Engel AG, Hohlfeld R (2004) The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C (eds) Myology. McGraw-Hill, New York, pp 1321-1366
50. Erdem S, Kissel JT, Mendell JR (2001) Toxic neuropathies: drugs,metals, and alcohol. In: Mendell JR, Kissel JT, Cornblath DR (eds) Diagnosis and management of peripheral nerve disorders. Oxford University Press, Oxford, pp 297-343
51. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, Zochodne DW (1986) An acute axonal form of Guillain-Barré polyneuropathy. Brain 109:1115-1126
52. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ (1993) Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 116:185-192
53. Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57-65
54. Fross RD, Daube JR (1987) Neuropathy in the Miller Fisher syndrome: Clinical and electrophysiological findings. Neurology 37:1493-1498
55. Fuller GN, Jacobs JM, Guiloff RJ (1993) Nature and Incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatry 56:372-381
56. Fuller GN, Jacobs JM, Lewis PD, Lane RJM (1992) Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy.A case with pupillary involvement. J Neurol Neurosurg Psychiatry 55:1079-1083
57. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288-1296
58. Gastaut JL (1995) Peripheral neuropathies in HIV infection. Rev Neurol (Paris) 151:532-540
59. Gemignani F, Marbini A, Pavesi G, Divittorio S, Manganelli P, Cenacchi G, Mancia D (1994) Peripheral neuropathy associated with primary Sjögren's syndrome. J Neurol Neurosurg Psychiatry 57:983-986
60. Govoni V, Granieri E (2001) Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14:605-613
61. Grant IA, Hunder GG, Homburger HA, Dyck PJ (1997) Peripheral neuropathy associated with sicca complex. Neurology 48:855-862
62. Green DM, Ropper AH (2001) Mild Guillain-Barré syndrome. Arch Neurol 58:1098-1101
63. Greenberg SA (1996) Acute demyelinating polyneuropathy with arsenic ingestion. Muscle Nerve 19:1611-1613
64. Griffin JW (2001) Vasculitic neuropathies. Rheum Dis Clin North Am 27:751-60, vi
65. Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 27:304-315
66. Griffin JW, Li CY, Ho TW, Xue P,Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR (1995) Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118:577-595
67. Guiloff RJ (1977) Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 40:801-807
68. Gutmann L (1999) Critical illness neuropathy and myopathy. Arch Neurol 56:527-528
69. Hartung H-P, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Muscle Nerve 18:154-164
70. Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG (1991) Vasculitic neuropathy. A clinical and pathological study. Brain 114:2175-2190
71. Herskovitz S, Schaumburg HH (2005) Neuropathy caused by drugs. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 2553-2583
72. Ho TW, Li CY, Cornblath DR, Gao CY, Asbury AK, Griffin JW, McKhann GM (1997) Patterns of recovery in the Guillain-Barré syndromes. Neurology 48:695-700
73. Hughes RAC, Britton T, Richards M (1994) Effects of lymphoma on the peripheral nervous system. J R Soc Med 87:526-530
74. Hull RG, Morgan SH, Harding AE, Hughes GR (1984) Sjogren's syndrome presenting as a severe sensory neuropathy including involvement of the trigeminal nerve. Br J Rheumatol 23:301-303
75. Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248:929-934
76. Hund EF (1996) Neuromuscular complications in the ICU: the spectrum of critical illness-related conditions causing muscular weakness and weaning failure. J Neurol Sci 136:10-16
77. Jacobs BC, Meulstee J, van Doorn PA, van der Meché FGA (1997) Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome. Muscle Nerve 20:446-452
78. Jacobs BC, Rothbarth PH, van der Meché FGA, Herbrink P, Schmitz PIM, deKlerk MA, van Doorn PA (1998) The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study. Neurology 51:1110-1115
79. Jamal G, Ballantyne JP (1988) The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). Brain 111:95-114
80. Jamal GA, MacLeod WN (1984) Electrophysiologic studies in Miller Fisher syndrome. Neurology 34:685-688
81. Kaplan JG, Rosenberg R, Reinitz E, Buchbinder S, Schaumburg HH (1990) Invited review: peripheral neuropathy in Sjögren's syndrome. Muscle Nerve 13:570-579
82. Katsuno M, Ando T, Hakusui S, Yanagi T, Sobue G (2002) Motor conduction studies in Miller Fisher syndrome with severe tetraparesis. Muscle Nerve 25:378-382
83. Kelkar P, Masood M, Parry GJ (2000) Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 55:83-88
84. Kiernan MC, Walters RJ, Andersen KV, Taube D, Murray NM, Bostock H (2002) Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain 125:1366-1378
85. Kissel JT, Collins MP, Mendell JR (2001) Vasculitic neuropathy. In: Mendell JR, Kissel JT, Cornblath DR (eds) Diagnosis and management of peripheral nerve disorders. Oxford University Press, Oxford, pp 202-232
86. Kissel JT, Mendell JR (1992) Vasculitic neuropathy. Neurol Clin 10:761-781
87. Krarup C (2002) Nerve conduction studies in selected peripheral nerve disorders. Curr Opin Neurol 15:579-593
88. Krarup C (2004) Compound sensory action potential in normal and pathological human nerves. Muscle Nerve 29:465-483
89. Krarup C, Crone C (2002) Neurophysiological studies in malignant disease with particular reference to involvement of peripheral nerves. J Neurol 249:651-661
90. Krarup C, Trojaborg W (1996) Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 119:257-270
91. Krarup-Hansen A (1996) Cisplatin neuropati hos mus og rotter. En elektrofysiologisk og histologisk vurdering af cisplatins påvirkning af perifere nerver og dorsale rodganglier. Copenhagen University, Copenhagen, pp 1-43
92. Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H (1999) Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 25:29-40
93. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC (2005) Altered motor nerve excitability in end-stage kidney disease. Brain 128:2164-2174
94. Kuwabara S, Nakata M, Sung J-Y, Mori M, Kato N, Hattori T, Koga M, Yuki N (2002) Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 199:89-92
95. Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N (1999) Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 67:180-184
96. Kuwabara S, Ogawara K, Sung J-Y, Mori M, Kanai K, Hattori T, Yuki N, Lin CS, Burke D, Bostock H (2002) Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol 52:180-187
97. Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy. Muscle Nerve 23:1785-1788
98. Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, Blake DM, Hirano M, Burns SM, Lovelace RE, Rowland LP (1992) Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology 42:497-505
99. Leger JM, Bouche P, Bolgert F, Chaunu MP, Rosenheim M, Cathala HP, Gentilini M, Hauw JJ, Brunet P (1989) The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry 52:1369-1374
100. Lennon VA (1994) Paraneoplastic autoantibodies: The case for a descriptive generic nomenclature. Neurology 44:2236-2240
101. Lewis RA (2005) Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies. Semin Neurol 25:217-228
102. Llewelyn JG, Tomlinson DR, Thomas PK (2005) Diabetic neuropathies. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier, Philadelphia, pp 1951-1991
103. Luco JV, Eyzaguirre C (1955) Fibrillation and hypersensitivity to ACh in denervated muscle: effect of length of degenerating nerve fibers. J Neurophysiol 18:65-73
104. Magistris MR, Rösler KM, Truffert A, Landis T, Hess CW (1999) A clinical study of motor evoked potentials using a triple stimulation technique. Brain 122:265-279
105. Malinow K, Yannakakis GD, Glusman SM, Edlow DW, Griffin J, Pestronk A, Powell DL, Ramsey-Goldman R, Eidelman BH, Medsger TAJ (1986) Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol 20:535-537
106. Manji H (2000) Neuropathy in HIV infection. Curr Opin Neurol 13:589-592
107. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333-342
108. McLeod JG (1981) Electrophysiological studies in the Guillain- Barré syndrome. Ann Neurol 9(Suppl):20-27
109. McLeod JG (1993) Paraneoplastic neuropathies. In: Dyck PJ, Thomas PK,Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy.WB, Saunders, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp 1583-1590
110. Mendell JR, Kissel JT, Cornblath DR (2001) Clues to the diagnosis of peripheral neuropathy: history and examination of the patient. In: Mendell JR, Kissel JT, Cornblath DR (eds) Diagnosis and management of peripheral nerve disorders. Oxford University Press, Oxford, pp 10-29
111. Miledi R, Slater CR (1970) On the degeneration of rat neuromuscular junctions after nerve section. J Physiol 207:507-528
112. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G (2005) The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 128:2518-2534
113. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T (2001) Clinical features and prognosis of Miller Fisher syndrome. Neurology 56:1104-1106
114. O'Leary CP, Willison HJ (1997) Autoimmune ataxic neuropathies (sensory ganglionopathies). Curr Opin Neurol 10:366-370
115. Oh SJ, Joy JL, Kuruoglu R (1992) "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 55:677-680
116. Oh SJ, Kim DE, Kuruoglu HR (1994) What is the best diagnostic index of conduction block and temporal dispersion? Muscle Nerve 17:489-493
117. Olney RK (1999) Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 22:S225-S229
118. Padua L, Aprile I, D'Amico P, Pauri F, Sabatelli M, Caliandro P, Tonali P (2001) A useful electrophysiological test for diagnosis of minimal conduction block. Clin Neurophysiol 112:1041-1048
119. Pardo CA, Mcarthur JC, Griffin JW (2001) HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst 6:21-27
120. Park EJ, Nishida T, Sufit RL, Minieka MM (2004) Prolonged compound muscle action potential duration in critical illness myopathy. Report of nine cases. Journal of Clinical Neuromuscular Disease 5:175-183
121. Pfeiffer G, Wicklein EM, Wittig K (2000) Sensitivity and specificity of different conduction block criteria. Clin Neurophysiol 111:1388-1394
122. Plaschke M, Ohly A, Trenkwalder C, Koenig E, Lechner C (1999) Critical illness polyneuropathy in intensive care patients. Neurologic manifestation, electrophysiological investigation, and clinical outcome. Aktuelle Neurologie 26:72-80
123. Price RW (1996) Neurological complications of HIV infection. Lancet 348:445-452
124. Rich MM, Bird SJ, Raps EC, Mc Cluskey LF, Teener JW (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20:665-673
125. Rich MM, Pinter MJ (2001) Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann Neurol 50:26-33
126. Rich MM, Pinter MJ (2003) Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547:555-566
127. Ridley A (1984) Porphyric neuropathy. WB, Saunders, Philadelphia, pp 1704-1716
128. Said G (1998) Vasculitic neuropathies. In: Latov N, Wokke JHJ, Kelly JJ (eds) Immunological and infectious diseases of the peripheral nerves. Cambridge University Press, Cambridge, pp 158-167
129. Said G (1999) Vasculitic neuropathy. Curr Opin Neurol 12:627-629
130. Said G, Goulon-Goeau C, Lacroix C, Moulonguet A (1994) Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 35:559-569
131. Said G, Lacroix C, Planté-Bordeneuve V, Le Page L, Pico F, Presles O, Senant J, Remy P, Rondepierre P, Mallecourt J (2002) Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 125:264-275
132. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, Bryan WW, Burns DK, Barohn RJ (1999) Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 22:560-566
133. Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ (1983) Sensory neuropathy from pyridoxine abuse. A new megavitamine syndrome. N Engl J Med 309:445-448
134. Schwarz J, Planck J, Briegel J, Straube A (1997) Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 20:696-701
135. Sghirlanzoni A, Pareyson D, Lauria G (2005) Sensory neuron diseases. Lancet Neurol 4:349-361
136. Shimamura H, Miura H, Iwaki Y, Kubodera T, Matsuoka T, Yuki N, Koga M (2002) Clinical, electrophysiological, and serological overlap between Miller Fisher syndrome and acute sensory ataxic neuropathy. Acta Neurol Scand 105:411-413
137. Smith KJ, Hall SM (2001) Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr Opin Neurol 14:289-298
138. Stefurak TL, Midroni G, Bilbao JM (1999) Vasculitic polyradiculopathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 66:658-661
139. Suarez JI, Cohen ML, Larkin J, Kernich CA, Hricik DE, Daroff RB (1997) Acute intermittent porphyria: clinicopathologic correlation. Report of a case and review of the literature. Neurology 48:1678-1683
140. Susuki K, Nishimoto Y, Yamada M, Baba M, Ueda S, Hirata K, Yuki N (2003) Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54:383-388
141. Susuki K, Odaka M, Mori M, Hirata K, Yuki N (2004) Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Neurology 62:949-956
142. Takada H, Ravnborg M (2000) Magnetically evoked motor potentials in demyelinating and axonal polyneuropathy: a comparative study. Eur J Neurol 7:63-69
143. Tankisi H, Pugdahl K, Fuglsang- Frederiksen A, Johnsen B, de CM, Fawcett PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS (2005) Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 116:1571-1580
144. Thomas PK (1997) Clinical features and investigation of diabetic somatic peripheral neuropathy. Clin Neurosci 4:341-345
145. Thomas PK, Ochoa J (1993) Clinical features and differential diagnosis. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral Neuropathy. WB, Saunders, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, pp 749-774
146. Trojaborg W (1990) Quantitative electromyography in polymyositis: a reappraisal. Muscle Nerve 13:964-971
147. Trojaborg W, Weimer LH, Hays AP (2001) Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy - a reappraisal. Clin Neurophysiol 112:1586-1593
148. van Mook WN, Hulsewe-Evers RP (2002) Critical illness polyneuropathy. Curr Opin Crit Care 8:302-310
149. Vilppula A (1972) Muscular disorders in some collagen diseases.A clinical, electromyographic and biopsy study. Acta Medica Scandinavica Suppl 540:7-47
150. Vucic S, Cairns KD, Black KR, Tick Chong PS, Cros D (2004) Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol 115:2329-2335
151. Willison HJ (2001) Fine specificity of anti-GQ1b antibodies and clinical features. J Neurol Sci 185:1-2
152. Willison HJ, O'Hanlon GM (1999) The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol 100:3-12
153. Wilmshurst P (1996) Critical illness polyneuropathy. Lancet 348:414
154. Windebank AJ (2005) Metal neuropathy. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 2527-2551
155. Winkelman C (2004) Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin Issues 15:74-82
156. Woittiez AJ, Veneman TF, Rakic S (2001) Critical illness polyneuropathy in patients with systemic inflammatory response syndrome or septic shock. Intensive Care Med 27:613
157. Yuki N, Kuwabara S, Koga M, Hirata K (1999) Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile. J Neurol Sci 168:121-126
158. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49:712-720
159. Zifko UA, Zipko HT, Bolton CF (1998) Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159:186-193
160. Zochodne DW (2005) Neuropathies associated with renal failure, hepatic disorders, chronic respiratory disease, and critical disease. In: Dyck PJ, Thomas PK (eds) Peripheral neuropathy. Elsevier Saunders, Philadelphia, pp 2017-2037